Antibodies and antigens for small molecule Metabolites/Chemicals-in Vitro diagnostics (IVD)
Table of Contents
Products Introduction
The small molecule Metabolite/Chemical entries, both water-soluble and lipid-soluble, are intended to be used for application in multiple disease detection, prognosis prediction, and metabolomics. Diagnostic chemicals and metabolites, including small peptides, are important biomarkers for evaluating and predicting physiological and Pathological conditions.
For instance, age-related bone loss, leading to osteoporosis, is accelerated by impaired calcium intake and low levels of 25-hydroxyvitamin D (25(OH)D). Reduced production of a significant precursor of vitamin D in the skin and reduced synthesis of active vitamin D metabolite (1,25(OH)2D) in the kidneys cause lower calcium absorption, subsequently, enhanced bone resorption. The calcium-related marker, 25-OH-VD, is useful to monitor the efficacy of anti-osteoporosis treatments and to predict fracture risk.
Product List
Cat No. | Species | Biomarker | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
|---|---|---|---|---|---|---|---|
Human |
|||||||
Human |
GMP-SMT-HFABPAg01:BSA-Human Fatty Acid Binding Protein (HFABP) ;GMP-SMT-HFABPAg02: OVA-Human Fatty Acid Binding Protein (HFABP) |
Competitive immunoassay-validated hapten-carrier conjugates BSA-& OVA-Human Fatty Acid Binding Protein (HFABP), Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade
inflammation) and related syndrome evaluation. |
GMP-SMT-HFABP-Ab01 Anti-Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb) |
Human Human Fatty Acid Binding Protein (HFABP) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade
inflammation) and related syndrome evaluation. |
|||
Human |
GMP-SMT-IGFBP-1Ag01:BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) ;GMP-SMT-IGFBP-1Ag02: OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) |
Competitive immunoassay-validated hapten-carrier conjugates BSA-& OVA-Insulin-like growth factor binding protein 1 (IGFBP-1), Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation. |
GMP-SMT-IGFBP-1-Ab01 Anti-Insulin-like growth factor binding protein 1 (IGFBP-1) mouse monoclonal antibody (mAb) |
Human Insulin-like growth factor binding protein 1 (IGFBP-1) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation. |
|||
Human |
Lithocholic Acid (LCA) |
GMP-SMT-LCAAg01:BSA-Lithocholic Acid (LCA) ;GMP-SMT-LCAAg02: OVA-Lithocholic Acid (LCA) |
Competitive immunoassay-validated hapten-carrier conjugates BSA-& OVA-Lithocholic Acid (LCA), Lithocholic Acid (LCA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
GMP-SMT-LCA-Ab01 Anti-Lithocholic Acid (LCA) mouse monoclonal antibody (mAb) |
Human Lithocholic Acid (LCA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
||
Human |
|||||||
Human |
GMP-SMT-LHAg01:BSA-Luteinizing hormone (LH) ;GMP-SMT-LHAg02: OVA-Luteinizing hormone (LH) |
Competitive immunoassay-validated hapten-carrier conjugates BSA-& OVA-Luteinizing hormone (LH), Luteinizing hormone (LH) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in LH level test of Hormone disorders (fertility) and related syndrome evaluation. |
GMP-SMT-LH-Ab01 Anti-Luteinizing hormone (LH) mouse monoclonal antibody (mAb) |
Human Luteinizing hormone (LH) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in LH level test of Hormone disorders (fertility) and related syndrome evaluation. |
|||
Human |
GMP-SMT-LP-PLA2Ag01:BSA-Phospholipase A2 (LP-PLA2) ;GMP-SMT-LP-PLA2Ag02: OVA-Phospholipase A2 (LP-PLA2) |
Competitive immunoassay-validated hapten-carrier conjugates BSA-& OVA-Phospholipase A2 (LP-PLA2), Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis,
hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. |
GMP-SMT-LP-PLA2-Ab01 Anti-Phospholipase A2 (LP-PLA2) mouse monoclonal antibody (mAb) |
Human Phospholipase A2 (LP-PLA2) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in LP-PLA2 level test of Metabolic diseases (atherosclerosis,
hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. |
|||
Human |
mycophenolic?acid (MPA) |
GMP-SMT-MPAAg01:BSA-mycophenolic acid (MPA) ;GMP-SMT-MPAAg02: OVA-mycophenolic acid (MPA) |
Competitive immunoassay-validated hapten-carrier conjugates BSA-& OVA-mycophenolic?acid (MPA), mycophenolic?acid (MPA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation. |
GMP-SMT-MPA-Ab01 Anti-mycophenolic acid (MPA) mouse monoclonal antibody (mAb) |
Human mycophenolic acid (MPA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation. |
||
Human |
|||||||
Human |
GMP-SMT-NorethisteroneAg01:BSA-Norethisterone ;GMP-SMT-NorethisteroneAg02: OVA-Norethisterone |
Competitive immunoassay-validated hapten-carrier conjugates BSA-& OVA-Norethisterone, Norethisterone antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Norethisterone level test of Hormone disorders (breast cancer) and related syndrome evaluation. |
GMP-SMT-Norethisterone-Ab01 Anti-Norethisterone mouse monoclonal antibody (mAb) |
Human Norethisterone binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Norethisterone level test of Hormone disorders (breast cancer) and related syndrome evaluation. |
GM-Solution for chemicals diagnostics and small molecule metabolites detection in the human body
GeneMedi Diagnostics Unit (GDU) is developing dynamic solutions for chemicals & metabolites immuno-assay-based rapid detection to improve application sensitivity, specificity, stability, and flexibility. Powered by G-SMSTM platform, GDU’s better small molecule biosensors contribute to small molecule metabolites’ rapid test application including ELISA test, competitive ELISA, Lateral flow immunoassay (LFA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Antigens for diagnostic chemicals and small molecule metabolites
The small molecule is hapten that hardly induces body immuno-reaction. To me both small molecule diagnosis and small molecule antibody discovery, the hapten-carrier conjugates are more applicable. The hapten-carrier conjugates for diagnostics chemicals and small molecule metabolites are also available in GDU products.
About G-SMS™
GeneMedi’s Small Molecule bioSensors discovery platform for more sensitive, specific and flexible small molecule detection.
Small molecule antigen & antibody list
Competitive immunoassay-validated anti-Hapten(small molecules, chemicals) antibody against hapten (small molecules, chemicals) and hapten-carrier conjugated competitive antigens(Carrier-coupled antigen,immunogen,hapten-carrier conjugates, BSA-conjugated, OVA-conjugated).
The anti-Hapten antibodies against haptens had been validated with our hapten-carrier conjugates via competitive ELISA test.
GeneMedi offers paired anti-small molecules (Chemicals, Antibiotics，Mycotoxins，Hormones，Drugs of Abuse, etc.) antibodies (monoclonal antibody, mab) and small molecules competitive antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated) for the rapid test and diagnostics kit of Growth Promoters, Toxic Heavy Metal, Myotoxins,Nutritions, Food Safety, Pesticides, Drugs of Abuse, Allergen, Antibiotics, Agricultural, Water Contamination and so on.
All our anti-chemicals antibodies and small molecules hapten-carrier conjugates antigens (BSA-conjugated, OVA-conjugated)are suitable for in competitive ELISA, Lateral flow immunoassay (LFIA) and other immunoassays in dignostics and rapid test kit. The carrier-coupled antigens of small molecules can act as immunogens.
Genemedi supplies Small Molecule Diagnostic for a wide selection of choices (please see below).
